VRXA Insider Trading Activity and SEC Form 4 Filings
VRXA insider trading summary
Over the past 12 months, insiders at Veraxa Biotech AG - Post de-SPAC (VRXA) reported 6 open-market purchases worth $135K by 5 insiders and no sales on SEC Form 4. Net insider buying was $135K.
Latest VRXA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 28, 2026 | Marc Gruninger | Director | Buy | $9K (9,133 @ $1.00) |
| Oct 27, 2026 | Marc Gruninger | Director | Buy | $850 (867 @ $0.98) |
| Oct 20, 2026 | Christoph Samuel Ziegler | Director | Buy | $33K (30,000 @ $1.09) |
| Sep 10, 2026 | Warren Hosseinion | Director | Buy | $10K (6,024 @ $1.67) |
| Aug 27, 2026 | Christoph Rudiger Antz | Chief Executive Officer | Buy | $8K (5,000 @ $1.53) |
| Aug 27, 2026 | Oliver Rolf Baumann | Director | Buy | $75K (50,000 @ $1.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.